You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 6, June 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Keratoacanthoma

A Clinical Study

John Kingman, MD; Jeffrey P. Callen, MD

Arch Dermatol. 1984;120(6):736-740.


Abstract

• Keratoacanthoma (KA) is a relatively common tumor believed to be a benign epidermal neoplasm. Ninety patients with one or more KAs were observed in regard to clinical, therapeutic, and prognostic implications. In particular, we were able to analyze the relationship of KA to internal malignant neoplasms in 78 patients. Keratoacanthoma is a disease of the elderly (mean patient age, 64.1 years). It is associated with other nonmelanoma cutaneous neoplasias in 21% of cases, a figure lower than that seen with squamous cell carcinomas. When solitary, KA is not associated with concurrent or subsequent internal malignant neoplasms more often than would be predicted by population statistics. Therapy is generally curative, but about 8% of the patients had recurrences. These patients may be successfully treated with several existing modalities.

(Arch Dermatol 1984;120:736-740)



Author Affiliations

From the Division of Dermatology, Department of Medicine, University of Louisville Health Sciences Center.


Footnotes

Accepted for publication June 24, 1983.

Reprint requests to 554 Medical Towers South, Louisville, KY 40202 (Dr Callen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

p53 Oncoprotein Expression and Gene Mutations in Some Keratoacanthomas
Perez et al.
Arch Dermatol 1997;133:189-193.
ABSTRACT  

Seasonality of Keratoacanthoma
Mantegna and Iuculano
Arch Dermatol 1995;131:1092-1092.
ABSTRACT  

Keratoacanthoma in Kauai, Hawaii: The First Documented Incidence in a Defined Population
Chuang et al.
Arch Dermatol 1993;129:317-319.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.